RpA1 ameliorates symptoms of mutant Ataxin-1 knock-in mice and enhances DNA damage repair
RpA1 ameliorates symptoms of mutant Ataxin-1 knock-in mice and enhances DNA damage repair
复制标题
RpA1改善突变Ataxin-1敲入小鼠的症状并增强DNA损伤修复
DOI:
10.1093/hmg/ddw272
复制
发表时间:
2016
影响因子:
3.5
通讯作者:
H.
中科院分区:
文献类型:
--
作者:
Taniguchi;JB.;Kondo;K.;Fujita;K.;Chen;X.;Homma;H.;Sudo;T.;Mao;Y.;Watase;K.;Tanaka;T.;Tagawa;K.;Tamura;T.;Muramatsu;SI.;Okazawa;H.
DNA damage and repair is a critical domain of many neurodegenerative diseases. In this study, we focused on RpA1, a candidate key molecule in polyQ disease pathologies, and tested the therapeutic effect of adeno-associated virus (AAV) vector expressing RpA1 on mutant Ataxin-1 knock-in (Atxn1-KI) mice. We found significant effects on motor functions, normalized DNA damage markers (γH2AX and 53BP1), and improved Purkinje cell morphology; effects that lasted for 50 weeks following AAV-RpA1 infection. In addition, we confirmed that AAV-RpA1 indirectly recovered multiple cellular functions such as RNA splicing, transcription and cell cycle as well as abnormal morphology of dendrite and dendritic spine of Purkinje cells in Atxn1-KI mice. All these results suggested a possibility of gene therapy with RpA1 for SCA1.